Citations

Clear

4610 citation(s) found for "Lu, Brian".

Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses
Han, Younghun , Byun, Jinyoung, Cooley, Matthew A. , Shaw, Vikram R., Ahmed, Fowsiyo , Giama, Nasra H., Ali, Hawa M. , Campbell, Nellie A. , Hassan, Mohamed, Andersen, Jesper B., Ankoma-Sey, Victor, Bañales, Jesús M. , Bujanda, L. , Bathe, Oliver F. , Bekaii-Saab, Tanios S., Borad, Mitesh J., Chan, Carlos H.F. , Cleary, S., Folseraas, Trine , Galle, P R, MacInnis, Robert J., Gores, Gregory J., Houlston, Richard S., Ilyas, Sumera, Javle, Milind, Johansen, Julia S., Christensen, Troels Dreier , Kamath, Ashwin S. , Kelley, Robin Kate , Lamarca, Angela, Lammert, F, Lindsey, Stacie , Macias, Rocio I. R., Patel, Tushar, Permuth, Jennifer B., Rossi, Stephen, Sanchez, William, Smoot, Rory L., Swerdlow, Anthony J., Cao, H. Tran, Valle, Juan, Weinmann, A., Wong, Linda L. , Zimmer, Vincent, Zhu, A., Kn, Lazaridis, Juran, Brian D., Jalal, Prasun Kumar, Knox, J., Hutchinson, Amy, Hicks, Belynda, Chanock, Stephen J., Hassan, Manal M. , Amos, Christopher I., McGlynn, Katherine A., Roberts, Lewis R., Roberts, Lewis R. , Sánchez, William , Han, Younghun , Byun, Jinyoung , Byun, Jinyoung , VanLith, Caitlin J. , Roberts, Lewis R , Banales, Jesus M , Jalal, Prasun K , Chan, Carlos H F , Sanchez, William , Shaw, Vikram R. , Hatia, Rikita , Andersen, Jesper B , Ankoma‐Sey, Victor, Bekaii‐Saab, Tanios , Borad, Mitesh J. , Björkström, Niklas K. , Cleary, Sean P. , Cornillet, Martin , Galle, Peter R., Genkinger, Jeanine M. , MacInnis, Robert J. , Gores, Gregory J. , Goyal, Lipika , Houlston, Richard S. , Ilyas, Sumera I. , Javle, Milind , Johansen, Julia S., Khan, Shahid Ali , Kim, Richard D. , Kwee, Sandi Alexander , Lamarca, Angela , LaRusso, Nicholas F. , Malhi, Harmeet , Permuth, Jennifer B. , Reeves, Helen L. , Smoot, Rory L. , Swerdlow, Anthony J , Weinmann‐Menke, Julia , Zhang, Xuehong , Zimmer, Vincent , Zhu, Andrew X. , Jalal, Prasun K. , Hutchinson, Amy , Hicks, Belynda , Koshiol, Jill , Chanock, Stephen Jacob , Amos, Christopher I. , McGlynn, Katherine A.

Mayo Clinic

Hepatology | February 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/hep.0000000000001699 | PMID 41627892 Get It

Background and Aims: Cholangiocarcinoma (CCA) is a rare but aggressive malignancy with poorly understood genetic susceptibility. To date, genome-wide association studies (GWAS) investigating germline variants associated with CCA risk remain limited. We aimed to identify genetic risk loci for CCA and its clinical subtypes through comprehensive GWAS and post-GWAS analyses. Approach and Results: We conducted a GWAS of 2366 CCA cases and 11,750 controls of European ancestry. Genome-wide significant loci ( p <5×10 −8 ) were identified and further examined through fine-mapping, functional annotation, and HLA imputation. Subgroup analyses were conducted by CCA subtypes and primary sclerosing cholangitis (PSC) status. Cross-trait linkage disequilibrium score regression and Mendelian randomization were employed to investigate the shared genetic architecture and potential causal relationships with a diverse range of traits. We identified 1 new genome-wide significant variant, rs535777 (OR=1.44), near HLA-DRB1/DQA1 associated with CCA, and 2 variants associated with extrahepatic CCA: rs116224263 (OR=0.17) in LINC02506 at 4p15.1 and rs6914950 (OR=1.63) near HLA-DRB1/DQB1 . Stratified analyses revealed rs2395184 (OR=3.51) near HLA-DRA/DRB5 associated with PSC-related CCA, and rs142674434 (OR=2.98) in THSD7A at 7p21.3 associated with non-PSC-related CCA. HLA imputation uncovered new amino acid residues associated with disease risk. Cross-trait analyses identified shared genetic signals between CCA and anthropometric, lipidemic, lifestyle, and medical traits. Mendelian randomization supported putative causal associations for 12 traits with CCA or its subtypes. Conclusions: Our large-scale GWAS highlights new genetic variants and HLA-linked mechanisms underlying CCA susceptibility. Integrating multi-step post-GWAS approaches enhances understanding of CCA pathogenesis and may facilitate the development of risk biomarkers for early detection and precision prevention strategies.
CyberKnife Stereotactic Radiosurgery for Vestibular Schwannomas: Systematic Review and Meta-Analysis of Long-Term Tumor Control and Hearing Preservation Outcomes
Pennington, Zach, Patel, Saarang, Rahmani, Redi , Gendreau, Julian, Stevens, Shawn M. , Lawton, Michael T., Pennington, Zach , Lawton, Michael T , Pennington, Zach , Brown, Nolan J. , He, Clifford Jiajun , Lien, Brian V. , Catapano, Joshua S , Lawton, Michael T.

Mayo Clinic

Neurosurgery Practice | February 2, 2026 | Volume: 7 | Issue: 1 | Pages: No page available

10.1227/neuprac.0000000000000202 | PMID 41630889 Get It

BACKGROUND AND OBJECTIVES: Stereotactic radiosurgery is a popular intervention for small vestibular schwannomas in patients with preserved hearing. Gamma Knife radiosurgery (GKRS) and CyberKnife radiosurgery (CKRS) represent 2 alternative modalities, with CKRS potentially allowing for the delivery of higher doses over multiple sessions. However, the optimal dosing and hearing outcomes of CKRS remain unclear. This study systematically reviewed all literature describing outcomes following treatment of vestibular schwannomas with CKRS, with a focus on tumor control, hearing preservation, and dosing schema. METHODS: The PubMed, Scopus, and Embase databases were queried to identify primary retrospective studies reporting local tumor control and hearing preservation rates following CKRS for vestibular schwannoma. Studies were reviewed, and the systematic review and meta-analysis were performed according to PRISMA and meta-analysis guidelines. RESULTS: Fifteen studies with study periods ranging from 1998 to 2018 were included. These studies comprised 2018 patients (mean age, 60.2 years; range, 11-91 years; 52% female), of whom 64 had neurofibromatosis type 2. The mean follow-up was 40 (range, 6-120) months, and 309 patients had undergone prior treatment (surgery and/or stereotactic radiosurgery). In aggregate, local control at the last follow-up was 96% (95% CI, 95%-98%), and 73% (95% CI, 66%-81%) of patients had preserved hearing. The most common major complications after CKRS were facial neuropathy (1.4%), trigeminal neuralgia (1.3%), and hydrocephalus (0.5%). CKRS provides a high rate of short-term and mid-term tumor control with hearing preservation comparable with GKRS, but long-term outcomes remain under investigated. CONCLUSION: This systematic review and meta-analysis found that CKRS offers high rates of tumor control and hearing preservation in patients undergoing stereotactic radiosurgery for vestibular schwannomas. Current data suggest that CKRS is a reasonable, safe therapeutic option for patients with small tumors and preserved hearing. Further exploration in larger cohorts and direct comparison with GKRS is merited.
Present Electrically Evoked Compound Action Potentials and Lack of Auditory Sensation Through a Cochlear Implant After Vestibular Schwannoma Resection
Kolberg, Courtney, Babajanian, Eric E. , DeJong, Melissa D., Deep, Nicholas L. , Dornhoffer, James R. , Neff, Brian A., Driscoll, Colin L.W., Carlson, Matthew L., Saoji, Aniket A. , Kolberg, Courtney, Driscoll, Colin L. W., Carlson, Matthew L.

Mayo Clinic

Otology & Neurotology | February 2, 2026 | Volume: 47 | Issue: 4 | Pages: e623-e626

10.1097/mao.0000000000004846 | PMID 41622559 Get It

Objective: Auditory nerve monitoring through electrically evoked compound action potentials (eCAP) can be used to assess cochlear neural integrity during vestibular schwannoma (VS) resection. Herein, we report on 5 cochlear implant (CI) patients who underwent VS resection with present eCAP responses both intraoperatively and postoperatively. Patients either did not perceive any sound through their CI or rapidly adapted to electrical stimulation, suggesting that the presence of eCAP does not guarantee auditory nerve function in patients with VS resection. Patients: Five patients who underwent simultaneous VS translabyrinthine resection and cochlear implantation. Interventions: Simultaneous cochlear implantation and translabyrinthine microsurgical VS resection. Main outcome measure: Electrically evoked compound action potential. Results: All patients had eCAP responses present during their VS resection and for at least 50 days post-surgery. Three of the 5 patients did not perceive any sound with their cochlear implant. This shows that the presence of an eCAP alone does not guarantee a functional auditory nerve or auditory perception. The other 2 patients could hear non-speech sounds, but these sounds quickly became inaudible, indicating that their auditory nerve lacked the ability to integrate the electrical stimulus over time. Conclusions: The presence of an eCAP response does not guarantee auditory sensation through a CI. Although eCAP measurements provide insight into the function of the distal end of the nerve, it does not ascertain integrity or function of the larger auditory nerve pathway. Therefore, eCAPs should not be used in isolation to monitor auditory nerve function during VS resection.
Clinical Manifestations, Long-Term Trends, and Risk Factors for Treatment Failure in Native Vertebral Osteomyelitis: A 26-Year Mayo Clinic Experience
Matsuo, Takahiro , Borgonovo, Fabio , Lahr, B. A., Petri, Francesco , Igwilo-Alaneme, Rita , Mulett, Sergio L Alvarez, Alavi, Seyed Mohammad Amin, Challener, Doug W, Nassr, Ahmad, Huddleston, Paul M, Berbari, Elie F. , Petri, Francesco , Matsuo, Takahiro , Lahr, Brian D. , Alvarez Mulett, Sergio , Challener, Douglas , Tande, Aaron , Berbari, Elie F , Borgonovo, Fabio , Alavi, Seyed Mohammad Amin , Challener, Douglas W. , Nassr, Ahmad , Huddleston, P.M. , Tande, Aaron J.

Mayo Clinic

Clinical Infectious Diseases | January 31, 2026 | Volume: 82 | Issue: 6 | Pages: e1171-e1180

10.1093/cid/ciag048 | PMID 41637568 Get It

Abstract Background Native vertebral osteomyelitis (NVO) is a life-threatening spinal infection with rising incidence and significant morbidity. Despite its growing burden, long-term data on clinical characteristics, management trends, and outcomes remain limited. Methods We conducted a 26-year multicenter retrospective cohort study of adults (≥18 years) diagnosed with NVO at Mayo Clinic sites between 1999 and 2024. Demographic, microbiologic, treatment, and outcome data were analyzed across five time periods. Predictors of treatment failure were assessed using a multivariable competing risk model. Results Among 1255 patients (median age 67; 66% male), lumbosacral involvement was most common (65%), and 21% had multilevel involvement. Pathogens were identified in 77%, most commonly Staphylococcus aureus (49%; Methicillin-susceptible S. aureus 37%, methicillin-resistant S. aureus 13%). Over time from 1999–2004 to 2020–2024, Gram-negative bacilli increased from 6% to 14% (P = .048). Comorbidities including chronic kidney disease (10% to 21%), active chemotherapy (6% to 11%), and immunosuppression (8% to 17%) increased significantly. Additionally, 1-year treatment failure declined (16% to 10%). In multivariable analysis, diabetes mellitus (subdistribution hazard ratio [sHR] 1.92, 95% CI 1.18–3.13) and multilevel involvement (sHR 1.67, 95% CI 1.17–2.38) were associated with increased incidence of treatment failure, while concurrent infections (sHR 0.57, 95% CI 0.37–0.87) and higher Charlson Comorbidity Index (sHR 0.62, 95% CI 0.43–0.90) were associated with lower failure. Conclusions This large multicenter cohort highlights increasing host complexity, shifting microbiology, and predictors of failure, emphasizing the importance of early risk stratification and tailored strategies, such as multidisciplinary evaluation and close follow-up of high-risk patients to improve outcomes.
Towards a standardized process of onboarding advanced practice providers into headache medicine practices in the United States: Expert consensus from the American Headache Society practice management committee
Cook, Calli , Freeman, Marshall C., Ailani, Jessica, Ehrlich, Annika , Grosberg, Brian M. , Kabbouche, Marielle A., Moriarty, Maureen, Secora, Karissa , VanderPluym, Juliana H. , Klein, Brad, Birlea, Marius , Directors, the American Headache Society Board of, Klein, Brad , VanderPluym, Juliana , Klein, Brad C , Ailani, Jessica

Mayo Clinic

Headache: The Journal of Head and Face Pain | January 31, 2026 | Volume: 66 | Issue: 2 | Pages: 502-510

10.1111/head.70038 | PMID 41618511 Get It

Abstract Objectives Discuss the current status of advanced practice providers (APPs) onboarding to headache medicine (HM) practices in the United States and present recommendations of the American Headache Society (AHS) APP Work Group to improve the onboarding process. Background A high demand for care, national shortage of specialists, and multiple advancements in HM have led to an increasing interest and presence of APPs of various backgrounds in the field, currently without a unifying onboarding process. Efforts to standardize and optimize the onboarding process for APPs in HM practices are necessary, to ensure high standards in quality of care. Methods The APP Work Group of the AHS Practice Management Committee developed comprehensive recommendations through literature review, survey of AHS members, and expert consensus. A modified Delphi protocol was used to establish key onboarding goals, definitions, and best practice recommendations. Results Recommendations are made regarding duration of onboarding, appropriate supervision, formal education and procedural skills, scope of practice, grading and documentation of competence, and reciprocal feedback. Conclusion Currently, there are no standard onboarding and training guidelines for APPs in the field of HM. We provide recommendations for a more systematic approach to help develop qualified providers and enhance their retention in HM practices.
Esophageal symptom burden remains high and associates with failed swallows after 5 years in patients with ineffective esophageal motility
Koop, Andree , Nimma, Induja R., Avaiya, Kevin , Jawish, Manar Al, Acuna, Einar V., Lacy, Brian E., Koop, Andree H , Al Jawish, Manar, Jawish, Manar Al , Lacy, Brian E.

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | January 31, 2026 | Volume: 330 | Issue: 3 | Pages: G315-G321

10.1152/ajpgi.00287.2025 | PMID 41617482 Get It

Patients with ineffective esophageal motility continue to experience significant symptoms years after diagnosis. In this survey of 47 patients diagnosed ≥5 years earlier, 45% reported GERD symptoms and 75% reported dysphagia. Greater numbers of failed swallows correlated with worse GERD and dysphagia scores, highlighting the long-term clinical impact of IEM and its association with esophageal symptom burden.
Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling
Dutt, Shubir , Leichter, Dana, Wolf, Amy , Kornak, John , Clark, Annie L , Russell, Lucy L. , Bouzigues, Arabella , Cash, David M, Bocchetta, Martina , Olzinski, Molly, Ece, Bayram, Borroni, Barbara, Butler, Chris R., Clark, David, Convery, Rhian S., Darby, R. Ryan , Mendonça, Alexandre de, Dickerson, Bradford, Domoto‐Reilly, Kimiko, Ducharme, Simon, Ferry‐Bolder, Eve, Finger, Elizabeth, Foster, Phoebe H. , Galasko, Douglas R., Galimberti, Daniela, Gerhard, Alexander, Ghoshal, Nupur , Graff, Caroline, Graff‐Radford, Neill, Grant, Ian M., Hales, Chadwick M., Honig, Lawrence S., Hsiung, Ging‐Yuek, Huey, Edward D, Irwin, David John, Jiskoot, Lize C., Kremers, Walter K. , Kwan, Justin Y., Laforce, Robert, Ber, Isabelle Le, Levin, J, Litvan, Irene, Mackenzie, Ian R., Masellis, Mario, Mendez, Mario F., Moreno, Fermin, Onyike, Chiadi U. , Otto, M, Pascual, Belen, Pressman, Peter , Rademakers, Rosa, Ramos, Eliana Marisa , Ritter, Aaron, Roberson, Erik D. , Sánchez‐Valle, Raquel, Santana, Isabel, Seelaar, Harro, Snyder, Allison, Sorbi, Sandro, Synofzik, Matthis, Tartaglia, Maria Carmela, Swieten, John C. van, Vandebergh, Marijne , Vandenberghe, Rik, Heuer, Hilary W. , Miller, Bruce L., Seeley, William W., Gorno‐Tempini, Maria Luisa, Kramer, Joel H., Forsberg, Leah K., Kantarci, Kejal, Boeve, Bradley F., Boxer, Adam L. , Rohrer, J. D., Rosen, Howard J., Staffaroni, Adam M., investigators, FTD Prevention Initiative (FPI), Graff, Caroline , Galimberti, Daniela , Otto, Markus , Jiskoot, Lize C. , Moreno, Fermín , Domoto‐Reilly, Kimiko , Russell, Lucy L , Bocchetta, Martina , Bayram, Ece , Ducharme, Simon , Finger, Elizabeth C. , Galimberti, Daniela , Ghoshal, Nupur , Irwin, David J , Kwan, Justin Y , Le Ber, Isabelle , Otto, Markus , Pascual, Belen , Snyder, Allison , Synofzik, Matthis , Tartaglia, Maria Carmela , Tiraboschi, Pietro , Kantarci, Kejal , Rohrer, Jonathan D , Roberson, Erik , Kremers, Walter K , Domoto-Reilly, Kimiko , Vandebergh, Marijne , Bouzigues, Arabella , Jiskoot, Lize C , Graff, Caroline , Cobigo, Yann , Cash, David M. , Appleby, Brian S. , Borroni, Barbara , Bozoki, Andrea C , Clark, David, Convery, Rhian , Mendonça, Alexandre de , Ducharme, Simon , Ferry‐Bolder, Eve , Galasko, Douglas , Gerhard, Alexander , Graff‐Radford, Neill R. , Hales, Chadwick M. , Honig, Lawrence S. , Hsiung, Ging‐Yuek Robin , Huey, Edward D. , Irwin, David J. , Kwan, Justin , Laforce, Robert , Ber, Isabelle Le , Léger, Gabriel C. , Xiong, Chengjie , Litvan, Irene , Mackenzie, Ian R. , Masellis, Mario , Mendez, Mario F. , Pascual, Belén , Rademakers, Rosa , Rowe, James B. , Sánchez‐Valle, Raquel , Santana, Isabel , Seelaar, Harro , Snyder, Allison , Sorbi, Sandro , Synofzik, Matthis , Tiraboschi, Pietro , Swieten, John C. van , Vandenberghe, Rik , Seeley, William W. , Gorno‐Tempini, Maria‐Luisa, Kramer, Joel H. , Forsberg, Leah K. , Kantarci, Kejal , Boeve, Bradley F. , Rohrer, Jonathan D. , Rosen, Howard J. , Staffaroni, Adam M.

Mayo Clinic

Annals of Neurology | January 29, 2026 | Volume: 99 | Issue: 5 | Pages: 1315-1326

10.1002/ana.78167 | PMID 41608854 Get It

Objective Age of symptom onset is highly variable in familial frontotemporal lobar degeneration (f‐FTLD). Accurate prediction of onset would inform clinical management and trial enrollment. Prior studies indicate that individualized maps of brain atrophy can predict conversion to dementia in f‐FTLD. We used a Bayesian linear mixed‐effect (BLME) prediction method for identifying accelerated brain volume loss to predict conversion to dementia. Methods Participants included 234 asymptomatic or prodromal carriers of C9orf72 , GRN , or MAPT mutations (including 21 dementia converters) with ≥3 longitudinal magnetic resonance imaging (MRI) T1‐weighted scans. The BLME models established individual voxel‐wise gray matter trajectories using the first 2 scans. Person‐specific clusters of accelerated volume loss were estimated in subsequent scans and tested as predictors of dementia conversion compared with other approaches in time‐varying Cox proportional hazard models covarying for age. Receiver‐operating characteristic (ROC) curves estimated utility of cluster volume in discriminating which participants converted to dementia within 24 months. Results The BLME cluster volume predicted conversion to dementia in f‐FTLD mutation carriers overall and separately in C9orf72 , GRN , and MAPT , with comparable hazard ratios observed for atrophy W‐maps and regional volumes. Within a 24‐month timeframe, BLME cluster volume discriminated dementia converters from non‐converters with larger areas under the curve (AUCs) than other approaches. Interpretation Bayesian‐modeled individualized atrophy scores predict dementia progression among asymptomatic f‐FTLD mutation carriers and may have increased utility compared with other structural imaging methods when studying individuals over shorter timeframes that align with clinical trial design. ANN NEUROL 20269999:n/a–n/a
Abstract WP127: Sex-Specific Differences in Presentation and Outcomes after Cervical Artery Dissection
Sidebottom, Christian, Omran, Setareh Salehi , Yaghi, Shadi, Shu, Ligi, Lee, Conner, Crandell, Ross, Lester, Evan, Henninger, Nils, Katheryna, Antonenko, Khan, Muhib, Mallick, Dania, Rothstein, Aaron, Khazaal, Ossama , Engelter, Stefan T, Traenka, Christopher , Gandhi, Preet , Metanis, Issa, Leker, Ronen, Renneberg, Regina Von, Guo, Xiaofan, Ghannam, Malik, AlMajali, Mohammad, Samaniego, Edgar A., Fonseca, Ana, Cruz, Diana , Romoli, Michele, Keser, Zafer, Marialuisa, Zedde, Bakradze, Ekaterina, Velez, Faddi Saleh, Penckofer, Mary , Siegler, J, Zubair, Adeel , Marto, Joao Pedro, Klein, Piers, Nguyen, Thanh N., Khasiyev, Farid, Elnazeir, Marwa , Elangovan, Cheran, Krishnaiah, Balaji , Henninger, Nils , Henninger, Nils , Muppa, Jayachandra , Gunduz, Muhammed Enes , Heldner, Mirjam R. , Nehme, Ahmad , Khan, Muhib , Rothstein, Aaron , Kaufmann, Josefin E. , Engelter, Stefan T. , Metanis, Issa , Leker, Ronen R , Shahripour, Reza Bavarsad , Ghannam, Malik , Samaniego, Edgar A , Cruz, Diana, Romoli, Michele , Keser, Zafer , Grory, Brian Mac , Bakradze, Ekaterina , Velez, Faddi G. Saleh , Siegler, James E. , Willey, Joshua , Marto, João Pedro , Klein, Piers , Nguyen, Thanh N. , Simpkins, Alexis N. , Elangovan, Cheran

Mayo Clinic

Stroke | January 29, 2026 | Volume: 57 | Issue: Suppl_1 | Pages: No page available

10.1161/str.57.suppl_1.wp127 Get It

Background and Objectives: Cervical artery dissection (CeAD) is a leading cause of ischemic stroke in younger adults, yet sex-specific variations in its clinical presentation, imaging characteristics, and outcomes remain underexplored. We aimed to evaluate these differences using data from a large, multicenter registry. Methods: We analyzed data from the STOP-CAD registry, which includes patients with radiologically confirmed non-traumatic CeAD enrolled between 2015 and 2021 across multiple centers. Clinical and imaging characteristics were compared between men and women using multivariable logistic regression. Outcomes assessed included ischemic stroke recurrence at 180 days, excellent functional outcome (modified Rankin Scale [mRS] 0–1) at 90 days, symptomatic intracerebral hemorrhage (sICH), and mortality. Results: Among 4,023 patients with CeAD, 1,783 (44.6%) were women. Compared to men, women were younger (median age: 42 vs 50 years), more likely to have a history of migraine (26.9% vs 8.3%) and connective tissue disorders (14.3% vs 5.8%), and presented more frequently with non-ischemic symptoms such as headache, neck pain, or tinnitus (adjusted OR [aOR] 2.0; 95% CI, 1.8–2.3; p<0.001). Women had significantly higher odds of vertebral artery dissection (OR, 1.3; 95% CI, 1.2-1.5; p<0.001), multivessel involvement (OR, 2.1; 95% CI, 1.7-2.5; p<0.001), and pseudoaneurysm formation (OR, 1.3; 95% CI, 1.1-1.6; p=0.003). Despite these differences, there was no significant sex-based difference in key clinical outcomes: excellent functional recovery at 90 days (OR 0.94; 95% CI 0.76-1.15 p=0.542), ischemic stroke recurrence at 180 days (OR 0.56 CI 0.23-1.3 p=0.213), or mortality (OR 0.83; 95% CI 0.47-1.48, p=0.529). Conclusion: In this large international cohort, we observed women with CeAD were younger, more likely to present with non-ischemic symptoms with distinct imaging features. These underscore the need for heightened clinical suspicion of CeAD in women presenting with atypical symptoms, even in the absence of ischemic deficits or conventional vascular risk factors, and suggest that sex-specific phenotyping may enhance diagnostic accuracy and early management.
Abstract WP047: Incidental Cerebral Aneurysms in Patients with Cervical Artery Dissection
Stretz, Christoph, Shu, Liqi , Mandel, Daniel M, Samaniego, Edgar A., Nguyen, Thanh N., Liebeskind, D, Guerrero, Christopher Leon, Arnold, Marcel, Omran, Setareh Salehi , Sousa, João André, Khan, Muhib, Rothstein, Aaron, Engelter, Stefan T, Sousa, Diana Aguiar de, FIELD, Thalia, Leker, Ronen, Dantu, Vishnu , Choi, Richard , Ghannam, Malik, Poppe, Alexandre, Romoli, Michele, Keser, Zafer, Frontera, Jennifer, Zedde, Marialuisa, MacGrory, Brian, Kasab, Sami Al, Bakradze, Ekaterina, Rodrigo-Gisbert, Marc, Velez, Faddi Saleh, Vishnu, Venugopalan, Yaddanapudi, Sridhara , Zubair, Adeel , Marto, Joao Pedro, Klein, Piers, Martins, Sheila, Krishnaiah, Balaji , Elangovan, Cheran, Qureshi, Abid, Mannino, Marina, Sarvath, Mohammed, Kass-Hout, T, Sen, Shayak, Elnazeir, Marwa , Furie, Karen, Yaghi, Shadi, Field, Thalia S. , Sousa, Diana Aguiar de , Field, Thalia S , Aguiar de Sousa, Diana , Stretz, Christoph , Samaniego, Edgar A , Leon Guerrero, Christopher R , Heldner, Mirjam R. , Arnold, Marcel , Nehme, Ahmad , Khan, Muhib , Rothstein, Aaron , Engelter, Stefan T. , Leker, Ronen R , Ghannam, Malik , Fonseca, Ana Catarina , Romoli, Michele , Keser, Zafer , Zedde, Marialuisa , Kasab, Sami Al , Bakradze, Ekaterina , Rodrigo‐Gisbert, Marc , Velez, Faddi G. Saleh , Vishnu, Venugopalan, Marto, João Pedro , Klein, Piers , Elangovan, Cheran , Mannino, Marina , VASILOPOULOU, SOFIA, Kass‐Hout, Tareq , Khan, Fahad

Mayo Clinic

Stroke | January 29, 2026 | Volume: 57 | Issue: Suppl_1 | Pages: No page available

10.1161/str.57.suppl_1.wp047 Get It

Background: Patients with cervical artery dissection (CAD) have a higher prevalence of cerebral aneurysms, likely due to underlying vasculopathies. Understanding risk factors and outcomes in this population may inform screening and management strategies. Methods: We conducted a post-hoc analysis of the STOP-CAD study, a multicenter international registry of patients with non-major trauma-related CAD across 63 centers. Cerebral aneurysms were identified based on medical history and intracranial vascular imaging obtained for dissection diagnosis. We compared demographic, clinical, laboratory, and imaging characteristics between patients with and without aneurysms. Variables with p<0.05 in univariate analysis were entered into a multivariable binary logistic regression to identify independent predictors. Clinical outcomes including ischemic stroke and symptomatic intracranial hemorrhage at follow-up were compared between both groups. Results: Out of 4023 patients included in the STOP-CAD study, 116 (2.9%) had at least one incidental cerebral aneurysm. In adjusted binary logistic regression, patients with cerebral aneurysm were more likely to have a history of migraine (aOR 1.78 95% CI 1.15-2.75, p=0.009), history of hypertension (aOR 1.65 95% CI 1.12-2.43, p = 0.010), known connective tissue disorder (aOR 3.47 95% CI 1.71-7.03), history of dissection (aOR 2.63 95% CI 1.31-5.28, p = 0.007), and a dissecting aneurysm at the site of the dissection (aOR 1.94 95% CI 1.25-3.01, p = 0.003). At follow-up, the presence of a cerebral aneurysm was not associated with ischemic stroke (7.8% vs. 5.6% p>0.1), but with a trend towards increased odds of symptomatic intracranial hemorrhage (3.4% vs. 1.2%, p = 0.062). Conclusions: Patients with CAD and concurrent incidental cerebral aneurysm were more likely to have a history of migraine headaches and markers of underlying vasculopathy and had a non-significantly increased risk of intracranial hemorrhage at follow-up. Further studies are needed to identify best practices for surveillance and risk stratification in this subgroup.